🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pulmonary Diseases

Anakinra Pilot 2 - A Study to Optimise Dose and Route of Administration of Anakinra in Preterm Infants NCT07254000Phase 22 sites📍 Clayton📍 Grafton Monash Medical Centre · Tests: Anakinra (Kineret®) Emphysema Research Registry and Biosample Repository NCT00307281n/a1 site📍 Pittsburgh University of Pittsburgh Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis NCT07809867Phase 41 site📍 Genova Istituto Giannina Gaslini · Tests: Elexacaftor, Tezacaftor, Ivacaftor, Ivacaftor (VX-770) Small Extracellular Vesicle miRNAs as Predictive Biomarkers for Immunochemotherapy Efficacy in Extensive-stage Small Cell Lung Cancer NCT07070011n/a1 site📍 Shanghai Shanghai Chest Hospital of Shanghai Jiao Tong University · Tests: EC/EP + ICIs An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting NCT06749886Phase 21 site📍 Shanghai Shanghai Pulmonary Hospital, Shanghai, China · Tests: Denosumab, tislelizumab, Docetaxel Continued Pressure for Alveolar Protection (CPAP Trial) NCT07417111NA15 sites📍 Birmingham📍 Palo Alto📍 San Diego NICHD Neonatal Research Network · Tests: CPAP, Nasal Cannula Effectiveness of Best Care Practices in Acute Stroke in Conventional Hospitalization (BEST CARE ICTUS_HC) NCT07627399NA4 sites📍 Antequera📍 Marbella📍 Ronda University of Malaga · Tests: BEST CARE ICTUS_HC BUNDLE Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil NCT05822193n/a1 site📍 Cachoeirinha Inova Medical · Tests: Multiple exposures Yoga Versus Health Education for the Treatment of Persistent Fatigue in Patients With Post COVID-19 Syndrome NCT05890599NA1 site📍 Stuttgart University Hospital Tuebingen · Tests: Yoga Therapy, Health Education Early Diagnosis of Invasive Lung Aspergillosis NCT05860387n/a7 sites📍 Havířov📍 Krnov📍 Ostrava University Hospital Ostrava · Tests: Next generation improvement of early invasive aspergillosis Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer NCT06775821n/a2 sites📍 Kunming📍 Kunming First Affiliated Hospital of Kunming Medical University · Tests: Ultrasound or CT of the abdominal aorta Gastric Emptying Time in Traumatic Injuries NCT06643325n/a1 site📍 Winterthur Kantonsspital Winterthur KSW · Tests: Gastric ultrasound A Real World Study of Ensartinib in Advanced ALK-positive NSCLC NCT05498064n/a1 site📍 Beijing Peking Union Medical College Hospital · Tests: Ensartinib Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation NCT05010109NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: 6 Minute Walk Functional Test, Biospecimen Collection, Computed Tomography, Echocardiography, Exercise Cardiac Stress T… A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC NCT06424899Phase 21 site📍 Hangzhou Zeng Jian · Tests: Adebrelimab, radical chemoradiotherapy, Platinum based chemotherapy Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung) NCT07120698Phase 22 sites📍 Guangzhou📍 Chengdu Guangdong Association of Clinical Trials · Tests: Sintilimab Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC NCT06162221Phase 1, Phase 298 sites📍 Gilbert📍 Duarte📍 Irvine Revolution Medicines, Inc. · Tests: RMC-6291, RMC-6236, Pembrolizumab, Cisplatin, Carboplatin ItAlian ReGistry Of pNeumoniA in immUnocompromised paTients (ARGONAUT) NCT06755814n/a1 site📍 Milan Societa Italiana di Pneumologia Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites📍 Los Angeles📍 New Haven📍 New Haven Pfizer · Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide DEPRECAP: Lung Cancer Screening Programme by LDCT for Patients With COPD or Emphysema. NCT06690385n/a2 sites📍 Madrid📍 Madrid Instituto de Investigación Sanitaria de la Fundación Jiméne… A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors NCT06936735Phase 11 site📍 Shanghai Hansoh BioMedical R&D Company · Tests: HS-20108 Monotherapy Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors NCT06107608NA1 site📍 Brussels Jules Bordet Institute · Tests: FAPI PET/CT TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients NCT06455917Phase 21 site📍 Basel University Hospital, Basel, Switzerland · Tests: TILs（Tumor Infiltrating Lymphocytes） APP-based Medical Device for Education and Training of Inhalation Technique NCT07145632NA3 sites📍 Uppsala📍 Styrsö📍 Boxholm Karolinska Institutet · Tests: App-based education and training of inhalation technique TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease NCT07295938Phase 28 sites📍 Beijing📍 Beijing📍 Guangdong Shanghai University of Traditional Chinese Medicine · Tests: Chinese herbs-I, Chinese herbs-I placebo, Chinese herbs-II, Chinese herbs-II placebo MRD-Guided Postoperative Surveillance and Adaptive Treatment for Resectable Lung Cancer NCT07894458NA1 site📍 Beijing Peking University People's Hospital · Tests: Adaptive therapy of de-escalation and escalation based on MRD testing and pathological response A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) NCT07373964Phase 21 site📍 Shenyang China Medical University, China · Tests: Chidamide Tablets； PD-L1 Inhibitor (as per chosen drug's prescribing information)；Carboplatin； Etoposide Apixaban in Thrombocytopenia NCT06886516EARLY Phase 11 site📍 Boston Rushad Patell · Tests: Apixaban A Study of Females With CF Throughout Pregnancy and Post-partum, and Follow up of Their Offspring NCT06797206n/a1 site📍 London Royal Brompton & Harefield NHS Foundation Trust DAOIB for the Treatment of Brain Fog NCT05764538Phase 21 site📍 Kaohsiung City Chang Gung Memorial Hospital · Tests: DAOIB
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy